Does a diabetes specialist team beat standard care for heart patients?

NCT ID NCT00248352

Completed Disease control Sponsor: Ottawa Heart Institute Research Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a team of specialists—an endocrinologist, diabetes educator, and dietician—could help people with type 2 diabetes and heart disease control their blood sugar better than standard care. 169 patients were split into two groups: one received usual care from their cardiologist or regular diabetes doctor, the other got extra counseling and a specialist consult. The main goal was to see if blood sugar levels (HbA1C) improved more with the team approach after 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Consultation with endocrinologist, counseling from dietician and diabetes educator
What this could lead to: If successful, this could show that specialized team-based care helps people with diabetes and heart disease better control their blood sugar.
What could go wrong: This is a small, completed study comparing care models, not testing a new drug. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Disease coronary artery disorder Coronary Disease diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY DISEASE DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

University of Ottawa Heart Institute

Ottawa, Ontario, K1Y 4W7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.